Ericka Kirkpatrick Roubidoux

Choosing the right tool for the job: A comprehensive assessment of serological assays for SARS-CoV-2 as surrogates for authentic virus neutralization

R. Webby, P. Thomas, S. Schultz-Cherry, 2021, medRxiv.

Animal Models Utilized for the Development of Influenza Virus Vaccines

S. Schultz-Cherry, Ericka Kirkpatrick Roubidoux, S. Schultz‐Cherry, 2021, Vaccines.

Novel epitopes of human monoclonal antibodies targeting the influenza virus N1 neuraminidase

H. V. Bakel, P. Wilson, V. Simon, 2021, bioRxiv.

SARS-CoV-2 antigen exposure history shapes phenotypes and specificity of memory CD8 T cells

Thomas P. Fabrizio, Jason R. Hodges, R. Webby, 2022, Nature Immunology.

Mutations in the Hemagglutinin Stalk Domain Do Not Permit Escape from a Protective, Stalk-Based Vaccine-Induced Immune Response in the Mouse Model

H. van Bakel, P. Wilson, F. Krammer, 2021, mBio.

Host Predictors of Broadly Cross-Reactive Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants of Concern Differ Between Infection and Vaccination

Thomas P. Fabrizio, Maureen A. McGargill, Jason R. Hodges, 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Utility of nasal swabs for assessing mucosal immune responses towards SARS-CoV-2

A. Souquette, P. Thomas, S. Schultz-Cherry, 2023, bioRxiv.

Utility of nasal swabs for assessing mucosal immune responses towards SARS-CoV-2

Paul G. Thomas, R. Webby, A. Souquette, 2023, Scientific reports.